Skip to main content
. 2019 Mar 10;15(5):1010–1019. doi: 10.7150/ijbs.29680

Figure 8.

Figure 8

Graphical abstract of how metformin inhibits the NLRP3 pathway via AMPK/mTOR-dependent effects in DCM.